Eminent Venture Capital is a private equity fund.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 8, 2015
Selecta Biosciences
|
Series E | $38M | Biopharma | — |
Jan 7, 2015
Tarveda Therapeutics
|
Series B | $21M | Biotechnology | — |
Oct 15, 2014
Selecta Biosciences
|
Private Equity(PE) | $20M | Biopharma | — |
May 5, 2008
Cardiva Medical
|
Series D | $15.50M | Health Care | — |
Sep 26, 2007
GlobeImmune
|
Series C | $41.20M | Biotechnology | — |
Eminent Venture Capital has had 4 exits. Eminent Venture Capital most notable exits include Cardiva Medical , GlobeImmune
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jan 20, 2021 | Cardiva Medical | M&A | Health Care | Detail |
Jul 5, 2016 | GlobeImmune | IPO | Biotechnology | Detail |
Jun 22, 2016 | Selecta Biosciences | IPO | Biopharma | Detail |
Jan 1, 2012 | Nereus Pharmaceuticals | M&A | Biotechnology | Detail |